Quantitative and preliminary clinical assessment of glycohypoxia as an oxygen-unloading defect linking chronic hyperglycemia to low-grade tissue hypoxia in type 2 diabetes: a targeted translational meta-regression with exploratory blood-sample validation
Frontiers in Clinical Diabetes and Healthcare · 15.07.2026 · 7
DOI: 10.3389/fcdhc.2026.1897413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Clinical Diabetes and Healthcare, online erschienen am 15.07.2026. Verfasst von Maher Akl und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Chronic hyperglycemia may impair tissue oxygen delivery by glycating hemoglobin, increasing oxygen affinity, shifting the oxyhemoglobin dissociation curve leftward, and reducing oxygen unloading, a state termed glycohypoxia. This study quantified HbA1c-dependent oxygen-release impairment and tested whether the modeled signal is supported by preliminary clinical validation in type 2 diabetes mellitus (T2DM).
Methods
Six human studies (1984–2012; N = 450) reporting HbA1c and oxygen-release metrics were synthesized using random-effects meta-regression. The pooled ΔP50 was translated into oxygen-unloading changes using the Hill equation across microvascular PO 2 values of 20–40 mmHg. In parallel, 90 T2DM patients were stratified by HbA1c into controlled, moderately uncontrolled, and poorly controlled groups for assessment of P50, 2,3-BPG, arterial oxygenation, SpO 2 –SaO 2 bias, lactate, and modeled unloading.
Results
Sensitivity-adjusted meta-regression showed ΔP50 = −0.19 mmHg per 1% HbA1c (95% CI: −0.26 to −0.11; P < 0.001; I2 = 45%), predicting 0.5–1.3% less oxygen unloading per 1% HbA1c and 1.5–3.9% cumulatively from HbA1c 6–9%. Clinically, higher HbA1c was associated with lower P50 (27.0 ± 0.5 to 26.2 ± 0.7 mmHg; P < 0.01), reduced 2,3-BPG (4.8 ± 0.4 to 4.2 ± 0.5 µmol/g Hb), increased SpO 2 –SaO 2 bias (+0.2 ± 0.4% to +1.8 ± 0.6%; P < 0.01), and higher lactate (1.2 ± 0.3 to 1.9 ± 0.5 mmol/L), despite preserved PaO2.
Conclusions
Quantitative modeling and exploratory clinical validation converged to support glycohypoxia as a measurable oxygen-handling phenotype in T2DM. This pattern may indicate a chronic low-grade functional hypoxic burden that accumulates with glycemic exposure and contributes to T2DM diabetic complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
- Department of Public Health, Riyadh First Health Cluster, Ministry of Health, Riyadh, Saudi Arabia.
Zitieren
APA
Akl, M., & Ahmed, A. (2026). Quantitative and preliminary clinical assessment of glycohypoxia as an oxygen-unloading defect linking chronic hyperglycemia to low-grade tissue hypoxia in type 2 diabetes: a targeted translational meta-regression with exploratory blood-sample validation. Frontiers in Clinical Diabetes and Healthcare, 7. https://doi.org/10.3389/fcdhc.2026.1897413
Vancouver
Akl M, Ahmed A. Quantitative and preliminary clinical assessment of glycohypoxia as an oxygen-unloading defect linking chronic hyperglycemia to low-grade tissue hypoxia in type 2 diabetes: a targeted translational meta-regression with exploratory blood-sample validation. Frontiers in Clinical Diabetes and Healthcare. 2026;7. doi:10.3389/fcdhc.2026.1897413
BibTeX
@article{Akl2026,
author = {Akl, Maher and Ahmed, Amr},
title = {Quantitative and preliminary clinical assessment of glycohypoxia as an oxygen-unloading defect linking chronic hyperglycemia to low-grade tissue hypoxia in type 2 diabetes: a targeted translational meta-regression with exploratory blood-sample validation},
journal = {Frontiers in Clinical Diabetes and Healthcare},
year = {2026},
volume = {7},
doi = {10.3389/fcdhc.2026.1897413}
}
EUVIMED